Elite Pharmaceuticals (ELTP) EV to EBIT (2020 - 2026)
Elite Pharmaceuticals' (ELTP) EV to EBIT stood at 10.28 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 49.3% from 20.29 a year earlier but up 41.2% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) EV to EBIT (2020 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' EV to EBIT came in at 8.02 as of Jun 30, 2026, down 58.8% year-over-year; for FY2026 (ended Mar 31, 2026), it was 7.28, down 68.9% from FY2025.
- Across earlier fiscal years, EV to EBIT came in at 23.38 in FY2025 (+65.2%), 14.15 in FY2024 (+134.7%), 6.03 in FY2023 (+40.3%) and 4.30 in FY2022 (-84.2%).
- Quarterly EV to EBIT has ranged from 2.55 in fiscal Q3 2023 to 46.66 in fiscal Q3 2025 over the past five years.
- On a year-over-year basis, EV to EBIT has declined for four consecutive quarters, with growth averaging 6.9% over the last eight quarters.
- Peak year-over-year performance for EV to EBIT in the last five years was growth of 702.2% in fiscal Q3 2024, against a decline of 84.2% in fiscal Q4 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 7.28 (Q4 2026), 10.11 (Q3 2026) and 15.67 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.28 |
| Mar 31, 2026 | 7.28 |
| Dec 31, 2025 | 10.11 |
| Sep 30, 2025 | 15.67 |
| Jun 30, 2025 | 20.29 |
| Mar 31, 2025 | 23.38 |
| Dec 31, 2024 | 46.66 |
| Sep 30, 2024 | 27.83 |
| Jun 30, 2024 | 15.69 |
| Mar 31, 2024 | 14.15 |
| Dec 31, 2023 | 20.42 |
| Sep 30, 2023 | 16.11 |
| Jun 30, 2023 | 7.30 |
| Mar 31, 2023 | 6.03 |
| Dec 31, 2022 | 2.55 |
| Sep 30, 2022 | 4.60 |
| Jun 30, 2022 | 9.86 |
| Mar 31, 2022 | 4.30 |
| Dec 31, 2021 | 7.31 |
| Sep 30, 2021 | 15.49 |
API Access
Elite Pharmaceuticals EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();